NURDAN TÖZÜN et al. Safety of peginterferon alfa-2a (40KD) treatment in patients with chronic hepatitis B infection: An observational, multicenter, open label, non-interventional study in Turkish patients. Turkish Journal of Gastroenterology, [S. l.], v. 23, n. 5, p. 552–559, 2019. Disponível em: https://turkjgastroenterol.avesjournals.com/index.php/tjg/article/view/2697. Acesso em: 10 jul. 2025.